Literature DB >> 8896507

Relationship of immune response to heat-shock protein A and characteristics of Helicobacter pylori-infected patients.

G I Pérez-Pérez1, J M Thiberge, A Labigne, M J Blaser.   

Abstract

Heat-shock protein A (HspA) is a GroES homolog in Helicobacter pylori. Using a recombinant HspA-maltose-binding protein fusion, the serologic response to HspA were determined. For 139 H. pylori-uninfected persons, responses to HspA were low-level or absent. In a survey of 273 infected persons, 105 (38.5%) were seropositive; there was no relationship between clinical outcome of infection and HspA seropositivity. Using paired sera obtained from 39 subjects (mean, 7.1 years apart), the stability of seroresponsiveness to HspA was examined. For 34 persons there was no change in status between the paired sera, but 5 (20%) of 25 initially seronegative persons seroconverted. The hypothesis that HspA seropositivity was related to patient age was examined using sera from 121 asymptomatic H. pylori-infected persons. Both the HspA seropositivity rate and the intensity of the response rose with age. In total, these findings indicate that HspA seropositivity is not universal but may be a consequence of prolonged H. pylori infection.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8896507     DOI: 10.1093/infdis/174.5.1046

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  11 in total

1.  Helicobacter pylori heat shock protein A: serologic responses and genetic diversity.

Authors:  E K Ng; S A Thompson; G I Pérez-Pérez; I Kansau; A van der Ende; A Labigne; J J Sung; S C Chung; M J Blaser
Journal:  Clin Diagn Lab Immunol       Date:  1999-05

2.  H pylori infection and systemic antibodies to CagA and heat shock protein 60 in patients with coronary heart disease.

Authors:  Cristina Lenzi; Alberto Palazzuoli; Nicola Giordano; Giuliano Alegente; Catia Gonnelli; Maria-Stella Campagna; Annalisa Santucci; Michele Sozzi; Panagiotis Papakostas; Fabio Rollo; Ranuccio Nuti; Natale Figura
Journal:  World J Gastroenterol       Date:  2006-12-28       Impact factor: 5.742

3.  rIL-22 as an adjuvant enhances the immunogenicity of rGroEL in mice and its protective efficacy against S. Typhi and S. Typhimurium.

Authors:  Gurpreet Kaur; Chitradevi STS; Charu Nimker; Anju Bansal
Journal:  Cell Mol Immunol       Date:  2014-05-26       Impact factor: 11.530

4.  Antigenic characterization of Helicobacter pylori strains from different parts of the world.

Authors:  J Höök-Nikanne; G I Perez-Perez; M J Blaser
Journal:  Clin Diagn Lab Immunol       Date:  1997-09

5.  Enhanced levels of Staphylococcus aureus stress protein GroEL and DnaK homologs early in infection of human epithelial cells.

Authors:  M W Qoronfleh; C A Bortner; P Schwartzberg; B J Wilkinson
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

6.  Induction and characterization of heat shock proteins of Salmonella typhi and their reactivity with sera from patients with typhoid fever.

Authors:  S W Tang; S Abubakar; S Devi; S Puthucheary; T Pang
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

7.  Anti-CagA immunoglobulin G responses correlate with interleukin-8 induction in human gastric mucosal biopsy culture.

Authors:  T Ando; G I Perez-Perez; K Kusugami; M Ohsuga; K C Bloch; M J Blaser
Journal:  Clin Diagn Lab Immunol       Date:  2000-09

8.  Longitudinal analysis of serological responses of adults to Helicobacter pylori antigens.

Authors:  Guillermo I Perez-Perez; Anna M Maw; Lani Feingold-Link; Jennifer Gunn; Andrea L Bowers; Cecilia Minano; Hilpi Rautelin; Timo U Kosunen; Martin J Blaser
Journal:  J Infect Dis       Date:  2010-09-15       Impact factor: 5.226

9.  Age-specific immune response to HspA in Helicobacter pylori-positive persons in Mexico.

Authors:  Peter P Eamranond; Javier Torres; Onofre Muñoz; Guillermo I Pérez-Pérez
Journal:  Clin Diagn Lab Immunol       Date:  2004-09

10.  Helicobacter pylori antibody responses in association with eradication outcome and recurrence: a population-based intervention trial with 7.3-year follow-up in China.

Authors:  Tianyi Wang; Yang Zhang; Huijuan Su; Zhexuan Li; Lian Zhang; Junling Ma; Weidong Liu; Tong Zhou; Weicheng You; Kaifeng Pan
Journal:  Chin J Cancer Res       Date:  2017-04       Impact factor: 5.087

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.